Toxic Optic Neuropathy [toxická neuropatie zrakového nervu]

topical
1
Terms

okulární toxicita
toxická neuropatie nervus opticus

 

Ocular Toxicity

Persistent link   https://www.medvik.cz/link/D000081028
Definition

Damage to the eye or its function (e.g., VISUAL IMPAIRMENT) due to OPTIC NERVE damage secondary to toxic substances such as drugs used in CHEMOTHERAPY; IMMUNOTHERAPY; or RADIATION.

DUI
D000081028 MeSH Browser
CUI
M000649533
Previous indexing
Eye Injuries (1964-2019); Vision Disorders/chemically induced (1971-2019)
History note
2020
Public note
2020

Allowable subheadings

BL
blood
CF
cerebrospinal fluid
CL
classification
CO
complications
DI
diagnosis 1
DG
diagnostic imaging
DH
diet therapy
DT
drug therapy
EC
economics
EN
enzymology
EP
epidemiology
EH
ethnology
ET
etiology
GE
genetics
HI
history
IM
immunology
ME
metabolism
MI
microbiology
MO
mortality
NU
nursing
PS
parasitology
PA
pathology
PP
physiopathology
PC
prevention & control
PX
psychology
RT
radiotherapy
RH
rehabilitation
SU
surgery
TH
therapy
UR
urine
VE
veterinary 1
VI
virology

C Diseases
C10 Nervous System Diseases 1 884
C10.292 Cranial Nerve Diseases 60
C10.292.200 Cranial Nerve Injuries 19
C10.292.200.750 Optic Nerve Injuries 12
C10.292.200.750.500 Toxic Optic Neuropathy 1
C10.292.700 Optic Nerve Diseases 118
C10.292.700.475 Optic Nerve Injuries 12
C10.292.700.475.500 Toxic Optic Neuropathy 1
C10.900 Trauma, Nervous System 64
C10.900.300 Craniocerebral Trauma 694
C10.900.300.218 Cranial Nerve Injuries 19
C10.900.300.218.550 Optic Nerve Injuries 12
C10.900.300.218.550.500 Toxic Optic Neuropathy 1
C11 Eye Diseases 1 495
C11.640 Optic Nerve Diseases 118
C11.640.530 Optic Nerve Injuries 12
C11.640.530.500 Toxic Optic Neuropathy 1
C23 Pathological Conditions, Signs and Symptoms 451
C23.550 Pathologic Processes 195
C23.550.035 Acantholysis 10
C23.550.073 Arrhythmias, Cardiac 2 797
C23.550.081 Ascites 335
C23.550.113 Atrial Remodeling 13
C23.550.145 Azotemia 5
C23.550.161 Cardiotoxicity 142
C23.550.177 Channelopathies 14
C23.550.210 Chromosome Aberrations 1 578
C23.550.260 Death 1 400
C23.550.274 Dehydration 403
C23.550.277 Delayed Graft Function 25
C23.550.288 Disease 1 712
C23.550.291 Disease Attributes 1 208
C23.550.308 Dysbiosis 107
C23.550.325 Emphysema 89
C23.550.340 Extravasation of Diagnostic and Therapeutic Materials 36
C23.550.347 Femoracetabular Impingement 27
C23.550.355 Fibrosis 366
C23.550.359 Frailty 122
C23.550.362 Genomic Instability 88
C23.550.369 Gliosis 37
C23.550.382 Granuloma 236
C23.550.384 Granulomatosis, Orofacial 6
C23.550.393 Growth Disorders 636
C23.550.403 Hemolysis 384
C23.550.414 Hemorrhage 2 296
C23.550.421 Hyperammonemia 31
C23.550.425 Hyperamylasemia 5
C23.550.429 Hyperbilirubinemia 184
C23.550.444 Hyperplasia 340
C23.550.449 Hyperuricemia 225
C23.550.455 Hypovolemia 87
C23.550.470 Inflammation 3 480
C23.550.505 Intraoperative Complications 717
C23.550.513 Ischemia 1 731
C23.550.522 Leukoaraiosis 4
C23.550.526 Leukocytosis 98
C23.550.537 Lithiasis 87
C23.550.543 Long Term Adverse Effects 7
C23.550.548 Malacoplakia 4
C23.550.568 Menstruation Disturbances 353
C23.550.589 Metaplasia 98
C23.550.695 Muscle Weakness 225
C23.550.706 Myotoxicity 1
C23.550.717 Necrosis 837
C23.550.722 Neointima 8
C23.550.727 Neoplastic Processes 130
C23.550.737 Nerve Degeneration 166
C23.550.744 Ochronosis 42
C23.550.751 Ossification, Heterotopic 139
C23.550.753 Ototoxicity 10
C23.550.755 Pigmentation Disorders 132
C23.550.759 Polydipsia 17
C23.550.767 Postoperative Complications 7 077
C23.550.770 Protein Aggregation, Pathological 16
C23.550.773 Respiratory Aspiration 79
C23.550.794 Retropneumoperitoneum 14
C23.550.823 Sclerosis 84
C23.550.835 Shock 410
C23.550.863 Teratogenesis 27
C23.550.877 Toxic Optic Neuropathy 1
C23.550.891 Ulcer 201
C23.550.918 Vascular Remodeling 29
C23.550.945 Yang Deficiency 9
C23.550.972 Yin Deficiency 9
C25 Chemically-Induced Disorders 30
C25.100 Drug-Related Side Effects and Adverse Reactions 5 054
C25.100.249 Akathisia, Drug-Induced 29
C25.100.311 Anticholinergic Syndrome 9
C25.100.389 Cardiotoxicity 142
C25.100.429 Chemotherapy-Related Cognitive Impairment 5
C25.100.468 Drug Hypersensitivity 545
C25.100.562 Chemical and Drug Induced Liver Injury 270
C25.100.656 Ototoxicity 10
C25.100.750 Dyskinesia, Drug-Induced 59
C25.100.781 Injection Site Reaction 12
C25.100.812 Metabolic Side Effects of Drugs and Substances 49
C25.100.828 Myotoxicity 1
C25.100.844 Propofol Infusion Syndrome 3
C25.100.875 Serotonin Syndrome 57
C25.100.937 Toxic Optic Neuropathy 1
C26 Wounds and Injuries 1 931
C26.733 Radiation Injuries 685
C26.733.031 Abnormalities, Radiation-Induced 8
C26.733.188 Acute Radiation Syndrome 14
C26.733.266 Cardiotoxicity 142
C26.733.345 Leukemia, Radiation-Induced 23
C26.733.411 Myotoxicity 1
C26.733.476 Neoplasms, Radiation-Induced 127
C26.733.579 Osteoradionecrosis 21
C26.733.650 Ototoxicity 10
C26.733.685 Radiation Fibrosis Syndrome 1
C26.733.720 Radiation Injuries, Experimental 467
C26.733.762 Radiation Pneumonitis 29
C26.733.804 Radiodermatitis 74
C26.733.853 Foveomacular Retinitis
C26.733.902 Toxic Optic Neuropathy 1

G Phenomena and Processes
G01 Physical Phenomena 79
G01.750 Radiation 226
G01.750.748 Radiation Exposure 108
G01.750.748.500 Radiation Injuries 685
G01.750.748.500.031 Abnormalities, Radiation-Induced 8
G01.750.748.500.188 Acute Radiation Syndrome 14
G01.750.748.500.266 Cardiotoxicity 142
G01.750.748.500.345 Leukemia, Radiation-Induced 23
G01.750.748.500.411 Myotoxicity 1
G01.750.748.500.476 Neoplasms, Radiation-Induced 127
G01.750.748.500.579 Osteoradionecrosis 21
G01.750.748.500.650 Ototoxicity 10
G01.750.748.500.685 Radiation Fibrosis Syndrome 1
G01.750.748.500.720 Radiation Injuries, Experimental 467
G01.750.748.500.762 Radiation Pneumonitis 29
G01.750.748.500.804 Radiodermatitis 74
G01.750.748.500.853 Foveomacular Retinitis
G01.750.748.500.902 Toxic Optic Neuropathy 1

Add